🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

What is melanoma and how can it be prevented? Shawn Demehri, MD, dermatologist and director for the High Risk Skin Cancer Clinic, explains how to check for the early signs of this skin cancer condition and the importance of a multidisciplinary approach to treatment.

Please be advised that there is significant police activity and traffic delays/possible road closures in the area of Mass General’s main campus/Cambridge Street due to a non-hospital related incident this morning. Please note that this is an isolated situation and the hospital is

Mike Kaelblein joins NBC10 Boston to discuss his journey of being diagnosed with esophageal cancer and receiving treatment at Mass General Brigham. Mathew Strickland, MD, and other members of his multidisciplinary team designed a research-driven treatment plan for his aggressive

An unforgettable day. Our team headed in to Mass General to watch our team manager Brady Cullen “Ring the Bell”. The strength and spirit he has show throughout this process has been absolutely remarkable -an inspiration to us all. North Reading Transcript Boston Globe Schools Danny Ventura

In August 2024, 16-year-old Brady's life changed in an instant. After experiencing facial numbness and hearing loss, he was diagnosed with a rare brain tumor called a pilocytic astrocytoma. Though typically slow-growing, Brady’s tumor was large and inoperable due to its location.

Thank you Conquer Cancer, the ASCO Foundation ASCO for granting me the Young Investigator Award for my work investigating resistance to next-gen #ALK inhibitors for #NSCLC. Enormously grateful for this opportunity & for the incredible mentorship of JessicaJLinMD, our amazing team, & our patients!

STARGLO update by Jeremy Abrahamson ⁦Mass General Cancer Center⁩ in the wake of the recent ODAC negative vote. #lymsm #ASCO25

🎉 Congratulations to Charlie Dai Mass General Cancer Center and Maxwell Lloyd BIDMC IM Residency on receiving a Young Investigator Award during #ASCO25!

Elizabeth R. Gerstner, MD, presented INCIPIENT Trial: Safety and Tolerability of Intraventricular CARv3-TEAM-E T Cells in Recurrent Glioblastoma at #ASCO25.

After facing sarcoma herself, Natasha Nathan was treated by Gregory Cote, MD, PhD. As a result, she’s now advocating for others fighting sarcoma. #ASCO25

At the #mNSCLC poster session at #ASCO25 we spoke with Rebecca Heist (Mass General Cancer Center) who presented early-phase data on MYTX-011, a c-Met directed ADC! Dose escalation study (1-8.3 mg/kg IV q3w) shows promising activity at ≥4 mg/kg across various c-Met expression levels.

Rachel Occhiogrosso Abelman, MD, presented her phase 2 trial for patients with early stage, triple negative breast cancer at #ASCO25.

📢 Rachel Occhiogrosso Abelman, MD unveils results from the NeoSTAR trial at #ASCO25 🔑 4 cycles of pre-op SG+P resulted in a 32% pCR rate in early-stage TNBC 🔑 No new safety signals identified 🔑 50% of patients achieved pCR with a non-anthracycline regimen (SG+P only or with additional NACT)

Thank you Fuck Cancer Events ASCO Conquer Cancer, the ASCO Foundation for funding the LEGACY study quantifying cancer risk in people w/ #lungcancer family history using #MachineLearning #AI This project wouldn’t have been possible without the mentorship of Lecia Sequist, MD, MPH + the guidance of Jill Feldman.

Laura Petrillo, MD, shares her poster on supportive and palliative care for patients living with advanced lung cancer. #ASCO25

Mass General Cancer Center few of our GI colleagues ready to watch our dear friend and colleague Sam Klempner discuss practice changing MATTERHORN study. Sam coined the term D-FLOT as the new SOC for peri operative therapy for patients with resectable gastric cancer.

National Cancer Survivor's Day is a day to #CelebrateLife and acknowledge the resilience, strength, and courage of those who have been affected by cancer. #NCSD2025 Pictured are some of our patient story participants.